Showing results (81-90 of 97) with videos related to
Sort By:
Pageof 10
Endocrinology|December 25, 2008
The secretogranin II-derived peptide secretoneurin stimulates luteinizing hormone secretion from gonadotrophsE Zhao, A Basak, A O L Wong, et al.Clinical Pharmacology and Therapeutics|December 26, 2025
Clinical Safety of Extended Interval Dosing of Nivolumab in Patients with MelanomaRuben Malmberg, Maaike M Hofman, Fatima Ashad, et al.Proceedings of the National Academy of Sciences of the United States of America|February 17, 1999
Mammalian subtilisin/kexin isozyme SKI-1: A widely expressed proprotein convertase with a unique cleavage specificity and cellular localizationN G Seidah, S J Mowla, J Hamelin, et al.Neurology|December 2, 2024
Patient-Relevant Digital-Motor Outcomes for Clinical Trials in Hereditary Spastic Paraplegia Type 7: A Multicenter PROSPAX StudyLukas Beichert, Jens Seemann, Christoph Kessler, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 11, 2026
Long-term survivors of melanoma after anti-PD-1 therapy demonstrate on-treatment increase in abundance of 4-1BB+ CD4 T cells in bloodKarlijn de Joode, Hayri E Balcioglu, Mandy van Brakel, et al.British Journal of Cancer|April 27, 2018
Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patientsSander Bins, Edwin A Basak, Samira El Bouazzaoui, et al.European Journal of Cancer (Oxford, England : 1990)|January 18, 2019
Correlation between nivolumab exposure and treatment outcomes in non-small-cell lung cancerEdwin A Basak, Stijn L W Koolen, Daan P Hurkmans, et al.European Journal of Cancer (Oxford, England : 1990)|August 21, 2022
Associations between patient and disease characteristics and severe adverse events during immune checkpoint inhibitor treatment: An observational studyEdwin A Basak, Niels S Vermeer, Karlijn de Joode, et al.Journal for Immunotherapy of Cancer|June 10, 2019
CD45RA+CCR7- CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumabAndre Kunert, Edwin A Basak, Daan P Hurkmans, et al.Journal for Immunotherapy of Cancer|May 29, 2020
Granzyme B is correlated with clinical outcome after PD-1 blockade in patients with stage IV non-small-cell lung cancerDaan P Hurkmans, Edwin A Basak, Nina Schepers, et al.Pageof 10